These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12685402)

  • 1. [New hypolipidemic drug from the HMG CoA reductase inhibitor group].
    Susekov AV; Zubareva MIu; Kukharchuk VV
    Ter Arkh; 2003; 75(2):81-4. PubMed ID: 12685402
    [No Abstract]   [Full Text] [Related]  

  • 2. Concern still warranted: medication burden and persistence with lipid-lowering drugs.
    Polinski JM; Gagne JJ
    Am J Manag Care; 2009 Jan; 15(1):74-5. PubMed ID: 19146367
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination therapy with HMG CoA reductase inhibitors and gemfibrozil: practical or perilous?
    Duell PB; Illingworth DR
    Heart Dis Stroke; 1993; 2(3):260-2. PubMed ID: 8137035
    [No Abstract]   [Full Text] [Related]  

  • 4. [What is assured in therapy with HMG-CoA reductase inhibitors (cholesterol synthesis inhibitors)?].
    Knisel W; Eggstein M
    Internist (Berl); 1989 Dec; 30(12):776-83. PubMed ID: 2695487
    [No Abstract]   [Full Text] [Related]  

  • 5. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets.
    Libby P; Aikawa M
    Nat Med; 2002 Nov; 8(11):1257-62. PubMed ID: 12411953
    [No Abstract]   [Full Text] [Related]  

  • 6. Statin-fibrate combination therapy.
    Feeman WE
    Am J Cardiol; 2008 May; 101(10):1521. PubMed ID: 18471475
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel approaches to the treatment of dyslipidemia.
    Rader DJ
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):480-1. PubMed ID: 15731488
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of sitagliptin on the pharmacokinetics of simvastatin.
    Bergman AJ; Cote J; Maes A; Zhao JJ; Roadcap BA; Sun L; Valesky RJ; Yang A; Keymeulen B; Mathijs Z; De Smet M; Laethem T; Davies MJ; Wagner JA; Herman GA
    J Clin Pharmacol; 2009 Apr; 49(4):483-8. PubMed ID: 19204138
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic implications of HMG CoA reductase inhibitors.
    White CM
    Conn Med; 2000 Sep; 64(9):533-5. PubMed ID: 11055086
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor from Pueraria thunbergiana.
    Kim HJ; Lee DH; Hwang YY; Lee KS; Lee JS
    J Agric Food Chem; 2005 Jul; 53(15):5882-8. PubMed ID: 16028969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spotlight on the effect of statins on stroke.
    Drug News Perspect; 2004 Sep; 17(7):461-2. PubMed ID: 15532126
    [No Abstract]   [Full Text] [Related]  

  • 12. Statin therapy in heart failure.
    Soaly E; Al Suwaidi J
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):5-7. PubMed ID: 15723569
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical inquiries. What are effective medication combinations for dyslipidemia?
    Saseen J; Tweed E; Crawford P
    J Fam Pract; 2006 Jan; 55(1):70-2. PubMed ID: 16388773
    [No Abstract]   [Full Text] [Related]  

  • 14. Bisphosphonates, statins, osteoporosis, and atherosclerosis.
    Watts N
    South Med J; 2002 Jun; 95(6):578-82. PubMed ID: 12081213
    [No Abstract]   [Full Text] [Related]  

  • 15. Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humans.
    Bergman AJ; Murphy G; Burke J; Zhao JJ; Valesky R; Liu L; Lasseter KC; He W; Prueksaritanont T; Qiu Y; Hartford A; Vega JM; Paolini JF
    J Clin Pharmacol; 2004 Sep; 44(9):1054-62. PubMed ID: 15317833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When a statin fails.
    Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290
    [No Abstract]   [Full Text] [Related]  

  • 17. HMG-CoA reductase inhibitors prevent bone loss in patients with Type 2 diabetes mellitus.
    Nakashima A; Nakashima R; Ito T; Masaki T; Yorioka N
    Diabet Med; 2004 Sep; 21(9):1020-4. PubMed ID: 15317608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Statines for all or individualized lipid lowering therapy?].
    Parhofer K
    MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
    [No Abstract]   [Full Text] [Related]  

  • 19. First-line therapies for lowering triglyceride levels.
    Raghavan VA
    Am Fam Physician; 2008 Feb; 77(4):416; author reply 417-8. PubMed ID: 18326158
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid disturbances in chronic renal failure--patomechanisms and treatment.
    Rutkowski B; Chmielewski M
    Rocz Akad Med Bialymst; 2004; 49():139-44. PubMed ID: 15631330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.